It can take up to 4 years to diagnose Autoimmune diseases*

Diagnosing Connective Tissue Diseases (CTD), such as Lupus, can be a painfully long and uncertain process. Because symptoms vary and are hard to differentiate, a blood test can help to identify CTD – sometimes even before symptoms become clear. The test helps physicians to rule out or confirm diagnosis by detecting autoantibodies associated with different Autoimmune diseases in the blood.

A comprehensive Autoimmune diagnostic solution

Our menu covers the eleven most clinically relevant CTD autoantibodies in one panel, providing laboratories and clinicians with more insights in one test and accelerating the time-to-results for the CTD diagnostic pathway.

The MosaiQ AiPlex CTD assay is designed for the simultaneous, qualitative detection of autoantibodies directed to double-stranded DNA and to the Extractable Nuclear Antigens TRIM21 (SS-A52, Ro-52), SS-A 60 (Ro-60), SS-B (La), Sm, Sm/RNP, U1RNP, Scl-70, Jo-1, CENP B, Ribosomal P Protein in human serum.

Clinically proven tests shorten time to diagnosis
Autoantibodies can be present up to 10 years before patients display specific symptoms. The MosaiQ AiPlex CTD assay can help detect disease early – possibly before specific clinical symptoms appear.  The most relevant autoantibodies that are part of clinical classification criteria are included in the MosaiQ AiPlex CTD assay.

Comprehensive panel
Covering the main CTD autoantibodies, the panel helps laboratories to accelerate time to results, and clinicians to diagnose the underlying CTD diseases or co-morbidities in one test instead of multiple – saving time without unnecessary follow-up appointments.

More insights, more clarity
More diagnostic insights empower clinicians to make better informed, personalized therapy choices early on, improving quality of care and reducing the burden of CTD illnesses for patients.